Anti-Claudin 1 Antibodies and Uses Thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160185856A1
SERIAL NO

14909362

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to anti-claudin 1 antibodies and their uses thereof. In particular, the present invention relates to an anti-Claudin 1 (CLDN1) antibody comprising n heavy chain variable region comprising SEQ ID NO:2 in the H-CDR1 region, SEQ ID NO:3 in the H-CDR2 region and SEQ ID NO:4 in the H-CDR3 region; and a light chain variable region comprising SEQ ID NO:6 in the L-CDR1 region, SEQ ID NO:7 in the L-CDR2 region and SEQ ID NO:8 in the L-CDR3 region.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS F75013
UNIVERSITÉ DE MONTPELLIER163 RUE AUGUSTE BROUSSONNET MONTPELLIER 34090
INSTITUT REGIONAL DU CANCER DE MONTPELLIER208 AVENUE DES APOTHICAIRES PARC EUROMEDICINE MONTPELLIER 34298

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DEL, RIO Marguerite Montpellier Cedex 5, FR 3 4
VEZZIO-VIE, Nadia Montpellier Cedex 5, FR 2 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation